Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



In vitro screening of multidrug resistance uropathogenic Escherichia coli from the urban area of Namakkal district

P. Poongothai,A. Gnanasekaran,P. Manikandan,P.K. Senthilkumar.




Abstract
Cited by 3 Articles

Objectives: To screen the multiple drug resistance (MDR) Uropathogenic Escherichia coli (UPEC) from the urban area of Namakkal district. To detect UPEC resistant by using different antibiotics. Analyzing the virulent characteristics of UPEC and amplification of ESBL genes by multiplex PCR. Methods: 450 urine samples were collected from the patients’ individually, followed by direct streaked on the EMB agar plates and incubated at 37 °C for 24 hours. significant growth indicates the E.coli. HiCrome UTI agar was used for rapid identification of uropathogenic E. coli. Results: Out of 450 samples only 62 isolates of E. coli were subjected to virulence characteristics like slime production (34%), hemolytic activity (56%), beta-lactamase production (43%). Antibiotic sensitivity test performed with 13 different antibiotics. Among the 62 isolates of E. coli, only 5 isolates were resistant to 10 antibiotics and possess virulence characters. Four strains (E-12, E23, E-58, E-97) have TEM, SHV and CTX-M antibiotic resistance genes, E-07 have only CTX-M gene. Conclusion: E. coli is the main infectious agent in patients with UTI and a potent pathogen, it was difficult to treat with routine antibiotics. Because day-by-day microbes are resisting to common drugs. So, need alternative therapy.

Key words: Multidrug resistance, Uropathogenic Escherichia coli, HiCrome UTI agar, Extended Spectrum Beta-lactamase, hemolytic, Slime, Multiplex PCR.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.